@JaneWilliams 1 day ago
$HIMS: Is This a Turning Point or More Pain?
$HIMS: Is This a Turning Point or More Pain?
Not gonna lie, Hims & Hers Health feels messy right now. The growth story is still there, but between heavy marketing spend, legal noise, and all the GLP-1 drama tied to Novo Nordisk, it’s hard to know what actually matters most.
The Eucalyptus deal sounds exciting, but big acquisitions always come with questions.
This feels like one of those moments where sentiment could flip fast either way. Are people betting on a real long-term brand, or was the weight-loss wave the main driver?
@SevenProblem148 1 day ago
Definitely a sentiment battleground. The long-term brand story is interesting, but near-term it still feels tied to GLP-1 momentum and execution on marketing spend. Could turn fast either way, clarity on sustainable growth will matter most.
